Mirae Asset Global Investments Co. Ltd. Boosts Stock Position in CME Group Inc. (NASDAQ:CME)

Mirae Asset Global Investments Co. Ltd. raised its position in CME Group Inc. (NASDAQ:CME - Free Report) by 52.6% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 66,525 shares of the financial services provider's stock after purchasing an additional 22,922 shares during the quarter. Mirae Asset Global Investments Co. Ltd.'s holdings in CME Group were worth $17,648,000 as of its most recent SEC filing.

A number of other large investors have also recently added to or reduced their stakes in the business. Bank Pictet & Cie Europe AG lifted its stake in CME Group by 29.0% during the 4th quarter. Bank Pictet & Cie Europe AG now owns 86,941 shares of the financial services provider's stock worth $20,190,000 after acquiring an additional 19,533 shares in the last quarter. NewEdge Wealth LLC raised its position in shares of CME Group by 10.1% during the 4th quarter. NewEdge Wealth LLC now owns 9,042 shares of the financial services provider's stock worth $2,100,000 after acquiring an additional 831 shares in the last quarter. Whipplewood Advisors LLC acquired a new position in shares of CME Group in the 4th quarter valued at $37,000. Oppenheimer Asset Management Inc. grew its holdings in shares of CME Group by 2.4% during the fourth quarter. Oppenheimer Asset Management Inc. now owns 14,971 shares of the financial services provider's stock worth $3,477,000 after purchasing an additional 353 shares during the last quarter. Finally, Parkside Financial Bank & Trust grew its position in shares of CME Group by 8.2% during the fourth quarter. Parkside Financial Bank & Trust now owns 1,200 shares of the financial services provider's stock worth $279,000 after acquiring an additional 91 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, Director Daniel G. Kaye sold 500 shares of CME Group stock in a transaction dated Thursday, May 22nd. The stock was sold at an average price of $282.42, for a total transaction of $141,210.00. Following the completion of the sale, the director now directly owns 3,668 shares in the company, valued at $1,035,916.56. The trade was a 12.00% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Derek Sammann sold 4,650 shares of the firm's stock in a transaction on Monday, May 5th. The shares were sold at an average price of $280.61, for a total transaction of $1,304,836.50. Following the transaction, the insider now owns 8,336 shares in the company, valued at $2,339,164.96. This represents a 35.81% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 13,400 shares of company stock valued at $3,680,610. Company insiders own 0.30% of the company's stock.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on the stock. Barclays increased their price target on shares of CME Group from $279.00 to $283.00 and gave the stock an "equal weight" rating in a report on Wednesday, April 23rd. UBS Group raised their target price on shares of CME Group from $290.00 to $305.00 and gave the stock a "buy" rating in a research report on Friday, April 25th. Raymond James Financial raised shares of CME Group from a "market perform" rating to an "outperform" rating and set a $287.00 price objective for the company in a research report on Monday, March 10th. Piper Sandler boosted their price objective on shares of CME Group from $275.00 to $283.00 and gave the stock an "overweight" rating in a report on Tuesday, April 8th. Finally, Keefe, Bruyette & Woods upped their target price on shares of CME Group from $265.00 to $273.00 and gave the company a "market perform" rating in a research note on Thursday, April 24th. Three investment analysts have rated the stock with a sell rating, eight have issued a hold rating and five have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus price target of $258.20.

CME Group Stock Performance

Shares of NASDAQ CME opened at $274.76 on Monday. CME Group Inc. has a 12-month low of $193.17 and a 12-month high of $290.79. The stock has a 50 day simple moving average of $275.21 and a 200-day simple moving average of $256.83. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. The company has a market cap of $99.01 billion, a PE ratio of 27.64, a P/E/G ratio of 3.73 and a beta of 0.45.

CME Group (NASDAQ:CME - Get Free Report) last issued its quarterly earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.61 by $0.19. The firm had revenue of $1.64 billion during the quarter, compared to analyst estimates of $1.56 billion. CME Group had a return on equity of 14.03% and a net margin of 57.71%. The firm's quarterly revenue was up 10.4% on a year-over-year basis. During the same period last year, the company posted $2.50 EPS. On average, equities research analysts forecast that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th were issued a $1.25 dividend. The ex-dividend date of this dividend was Monday, June 9th. This represents a $5.00 annualized dividend and a dividend yield of 1.82%. CME Group's dividend payout ratio is currently 50.30%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.